Clinical Implications of Combined Portal Vein Resection as a Palliative Procedure in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Head Carcinoma

Kazuaki Shimada MD; Tsuyoshi Sano MD; Yoshihiro Sakamoto MD; Tomoo Kosuge MD

首页> 外文期刊>Annals of Surgical Oncology >Clinical Implications of Combined Portal Vein Resection as a Palliative Procedure in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Head Carcinoma

【24h】

Clinical Implications of Combined Portal Vein Resection as a Palliative Procedure in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Head Carcinoma

机译：胰头十二指肠切除术治疗胰头癌的患者联合门静脉切除作为姑息治疗的临床意义

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The clinical implications of combined portal vein resections are controversial.

机译：合并门静脉切除术的临床意义尚存争议。

著录项

来源
《Annals of Surgical Oncology》 |2006年第12期|1569-1578|共10页
作者
Kazuaki Shimada MD; Tsuyoshi Sano MD; Yoshihiro Sakamoto MD; Tomoo Kosuge MD;
展开▼
作者单位

Department of Hepatobiliary and Pancreatic Surgery National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104-0045 Japan;

Department of Hepatobiliary and Pancreatic Surgery National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104-0045 Japan;

Department of Hepatobiliary and Pancreatic Surgery National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104-0045 Japan;

Department of Hepatobiliary and Pancreatic Surgery National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104-0045 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Pancreatic cancer; Portal vein resection; Predictive factors; Recurrence pattern; Postoperative complications;

机译：胰腺癌;门静脉切除;预测因素;复发模式;术后并发症;

相似文献

外文文献
中文文献
专利

1. The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy [J] . Jaseanchiun Warakorn, Kato Hiroyuki, Hayasaki Aoi, Nature reviews Cancer . 2019,第2期

机译：门静脉通畅比在术前化学疗法术后门静脉组合胰岛切除术治疗胰腺癌腺癌患者预后的临床影响
2. The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy [J] . Jaseanchiun Warakorn, Kato Hiroyuki, Hayasaki Aoi, Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] . 2019,第2期

机译：门静脉通畅比在术前化学疗法术后门静脉中胰腺切除术治疗胰腺癌腺癌患者预后的临床影响
3. The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis [J] . Cheng Peng, Di Zhou, Lingjun Meng, BMC Surgery . 2019,第1期

机译：联合胰十二指肠切除术在胰头癌中的价值：一项荟萃分析
4. Pancreatic carcinoma: surgery, palliative resection and value of lymph node resection [C] . C. MICHALSKI, J. KLEEFF, M. W. BUCHLER, Falk Symposium . 2006

机译：胰腺癌：手术，姑息治疗和淋巴结切除的价值
5. Does pancreaticoduodenectomy with venous resection increase median survival when compared to palliative therapy in patients with borderline resectable pancreatic adenocarcinoma of the head of the pancreas? [D] . Lennon, Erin Frances 2010

机译：与颅底可重型胰腺腺癌患者的痛苦治疗相比，胰腺切除术治疗中位生存率是否增加了胰腺的头部胰腺炎的患者？
6. Laparoscopic pancreaticoduodenectomy with segmental resection of superior mesenteric vein-splenic vein-portal vein confluence in pancreatic head cancer: can it be a standard procedure? [O] . Hyejin Park, Incheon Kang, Chang Moo Kang 2018

机译：腹腔镜胰十二指肠切除术联合部分切除肠系膜上静脉-脾静脉-门静脉汇合在胰腺癌中的治疗：这可以作为标准方法吗？
7. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

机译：表5.5.a.1肿瘤大小和治疗（重新切性率）图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度，TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后，患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时，围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后，患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头

Clinical Implications of Combined Portal Vein Resection as a Palliative Procedure in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Head Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅